Regulatory Open Forum

 View Only
  • 1.  EU MDR and acceptance of ASTM standard

    This message was posted by a user wishing to remain anonymous
    Posted 02-Aug-2022 09:42
    This message was posted by a user wishing to remain anonymous

    Hi all,

    Does anybody know whether the EU Notified Bodies accept shelf-life testing of non-sterile medical devices compliant with the American ASTM-F1980? It looks like there is no generic European standard published for non-sterile medical devices, and the ASTM seems to be the most appropriate one.

    Thank you


  • 2.  RE: EU MDR and acceptance of ASTM standard

    Posted 02-Aug-2022 12:56
    Edited by Somashekara Koushik Ayalasomayajula 02-Aug-2022 12:56
    Hi,

    It is a bit tricky to answer as there is no standardised approach and NBs have different practices. Also at the same time, I do not see any reason why notified bodies reject such testing strategy. Assuming you have a non-sterile device which includes a material degrading over time or any parameter/ component that may change over time (which makes your device no longer function as intended), then you can use ASTM-F1980 provided you can justify the conditions selected for the shelf life testing are representing accelerated conditions to identify such changes and hence support for determining product performance.
    Hope that helps!
    Best, Koushik

    ------------------------------
    Somashekara Koushik Ayalasomayajula
    -Ing.
    Garching bei München
    Germany
    ------------------------------



  • 3.  RE: EU MDR and acceptance of ASTM standard

    Posted 03-Aug-2022 03:24
    Hello Anon,

    There has been many threads in this forum generated about use of standards, harmonised standards (listed under EU MDD/IVDD or listed under EU MDR/IVDR), state of the art discussions, and ultimately what a "list of standards" would look like in a Technical Documentation.  Unfortunately as mentioned by Koushik there are disparities between Notified Bodies and even within Notified Bodies.  They should recognise standards which are used as best practice and recognised internationally even though a standard may be published by another national authority.  Sadly they do not always recognise standards.  When using standards, your list of standards should be promulgated with reasons or justifications on standards applied.  Auditors and reviewers should understand medical device manufacturers do not sell only in Europe and the European way is not the centre of the universe, that there are many other standards, guidance, regulations, and other best practices out there in the wide world.  Steps of the soap box ... but really it is about time reviewers and auditors (Notified Bodies) use some common sense and practicality.  I agree using a standard such as ASTM F1980 for shelf-life testing is appropriate and unless the European Union or the Notified Body reviewer/auditor can cite a specific standard or regulation for shelf life testing ... then can be best practice and state of the art (the closest we have is ISO 23640 for stability of IVD medical devices).

    ------------------------------
    Richard Vincins ASQ-CQA, MTOPRA, RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 4.  RE: EU MDR and acceptance of ASTM standard

    Posted 03-Aug-2022 04:30
    Dear Anon,

    I do not see any huge problem.
    >> For me the rational for the selection of a test method, etc. has to be given in the context of the foreseeable use cases.
    Here it may be a risk control applicable to the "cleanness" and "readiness" of the MD. 

    Anyhow, I would proactively answer the question, why a standard for sterile systems (link) is applied to non-sterile MD 
    PS ASTM-F1980 refers to ISO 11607-1  which is also published as European standard (link)?

    ------------------------------
    Uwe Zeller | Regulatory Affairs / Risk Management Consultant
    Biberach an der Riß, Germany
    ------------------------------



  • 5.  RE: EU MDR and acceptance of ASTM standard

    Posted 04-Aug-2022 06:41
    The title and wording in ASTM 1980-21 (note the version is now 2021) was subtly modified to state that if course it can be used as a reference for non-sterile devices.

    That was an interesting development, and I have seen more than a few companies using its structure to set up accelerated aging for their products.  The concept of Arrhenius and Q10 is not restricted to sterile devices.

    ------------------------------
    Ginger Cantor, MBA, RAC
    Founder/Principal Consultant
    Centaur Consulting LLC
    River Falls, Wisconsin 54022 USA
    715-307-1850
    centaurconsultingllc@gmail.com
    ------------------------------



  • 6.  RE: EU MDR and acceptance of ASTM standard

    Posted 03-Aug-2022 04:34
    Hi Anon,

    First of all, this is not just an American standard. This is published as an international standard by the Standards Development Organization (SDO) ASTM International. While it is not published in the Official Journal (OJ) as a Harmonised standard, it is for international use (just like an ISO or IEC standard). It is time that we all hold the Notified Bodies accountable to simply follow the rules and not allow them to make an interpretation that is NOT valid. A standard not being publish in the OJ (or not on the FDA recognized list) does NOT invalidate that standard. As we have experienced, there are other issues at play here in those processed to get the list published and that gets in the way of the process. We as an industry need to set the rules here and they also need to play by those rules.

    1) If there is sufficient information in the regulation, this takes precedence
    2) If there is a published list of recognized standards (published in the OJ/FDA list), this is next
    3) Other relevant international standards (yes, if published by a country/region specific one, you should use that one for the country you are marketing the product) and guidance--note that country participation in an international SDO often comes with agreements (like the Vienna agreement) that they will not change the normative portions of standards
    4) Other industry or country standards
    5) sector or company standards--this can often require additional validation

    Understand, this can create some conflicts and those may need to be discussed, but we all need to understand the agreements that are behind the SDO and this is why the Notified Body has to register with an Accreditation Body (they are the ones to hold them to the rules).

    ------------------------------
    Regards,
    Mark Swanson, ASQ CBA, CMQ/OE, CQE ASQ, MBA
    Becker MN
    United States
    ------------------------------



  • 7.  RE: EU MDR and acceptance of ASTM standard

    Posted 03-Aug-2022 05:21
    Well said Mark.  As medical device manufacturers, we do need to hold Notified Bodies, all of them and in completeness, accountable to understand context of regulatory aspects.  In addition, time and time again I see Notified Bodies "making things up" as they go along because they do not have the understanding and knowledge of their own quality management processes or how these relate to international processes such as SDO.

    ------------------------------
    Richard Vincins ASQ-CQA, MTOPRA, RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 8.  RE: EU MDR and acceptance of ASTM standard

    Posted 03-Aug-2022 13:49
    Great information provided thus far regarding the Forum-well-trodden aspects of the EU MDR's approach to conformity with the state-of-the-art vs. harmonized standards vs. non-harmonized standards etc., so I have nothing further to add there.

    But with particular respect to the appropriateness of using ASTM F1980 for shelf-life testing of non-sterile medical devices, here are some additional points to consider:

    • ASTM F1980 is primarily focused on the accelerated aging stability study of sterile barrier systems (SBS) [i.e., the minimum package that minimizes the risk of ingress of microorganisms and allows aseptic presentation of the sterile contents at the point of use (per ISO 11607-1:2019 )].
    • Although the scope of ASTM F1980's latest version (2021) was broadened to also allow its generalized use for accelerated aging protocols for medical devices and medical device materials, there is precious little therein to guide us on the aging and stability study of devices and device materials except for the application of the Arrhenius reaction rate accelerated aging theory.  In other words, while ASTM F1980-21 contains good guidance (by integration of various peripheral package testing standards) for how to assess the integrity of an SBS after aging, it gives little, if any, guidance about how to assess medical device or device material integrity after aging.
    • Consequently, you'll need to carefully assess ASTM F1980-21's true value for your non-sterile medical device shelf life testing goals.  For example, is your question focused more on assessing the post-aging package integrity for a non-sterile device?  If so, then ASTM F1980-21's packaging-related integrity/stability test methods could be quite adaptable for use as guidance for your aged non-sterile package integrity testing goals.
    • In contrast, if you are instead more focused on post-aging medical device stability/integrity, or medical device material stability/integrity, then ASTM F1980-21 offers little more than just the Arrhenius reaction rate accelerated aging theory.  Indeed, it doesn't discuss (unless I missed it) how to assess device stability/integrity or device material stability/integrity.
    • The U.S. FDA's old medical device shelf life testing guidance document is a go-to resource for me for better insights on post-aging device or device material integrity testing.  It is based on principles from the USP.  Globally, I know of no other such useful generalized resource, and have successfully applied it as a state-of-the-art way to approach the topic.
    • In this case, I'd say you will ultimately need to 1) specifically decide what aspects (e.g., the Arrhenius reaction rate theory) of ASTM F1980-21 you will apply; 2) identify what other generally recognized methods you will employ (e.g., principles from other resources like the FDA's shelf life guidance); and 3) draw up a rationale justifying your customized conformity assessment approach under the corresponding allowance of EU MDR Annex II.4 first paragraph and indent (b), along with corresponding leaning on the MDCG's MDCG 2021-5 acknowledgment of the EU MDR legislative reality that, "...it is not possible to impose the use of a specific standard in the conformity assessment of a product..."

    Hope this helps.

    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2022 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------



  • 9.  RE: EU MDR and acceptance of ASTM standard

    Posted 04-Aug-2022 13:47
    Hi All,

    One thing that hasn't been brought up in this discussion thread is the MDCG 2021-05 Guidance on Standardisation for medical devices.  In section 2.2 "Voluntary use of standards" the last paragraph it clearly states  National authorities and Notified Bodies aren't allowed to impose the use of any specific standard.  Below is verbatim the paragraph:

    "Therefore, also in the medical devices field in the EU, choosing to use a standard or not belongs to the manufacturer, within its overall and ultimate responsibility on compliance. With the possible exceptions referred to above, it is not possible to impose the use of any specific standard, on the basis for instance of its status of harmonised European standard or of "state-of-the-art" standard, neither by national authorities in their market surveillance or vigilance activities, nor by notified bodies in the conformity assessment procedures they participate in. Actually, to be lawfully placed on the EU market, medical devices must comply with the health, safety and performance requirements of the applicable legislation, and not necessarily with the clauses of a standard. Conversely, compliance of a device must be assessed against the legal requirements that apply to it, and this may be made through compliance with the clauses of a standard (regardless of whether the standard is cited in the OJEU or not), but not necessarily, unless the manufacturer would claim compliance with the legal requirements by using a harmonised European standard cited in the OJEU thus conferring presumption of conformity. "

    The exception talked about in the above paragraph is "
    At the same time, it is worth noting that for medical devices there are "exceptions that proves the rule" when standards can be regarded as mandatory: it is the case of symbols and identification colours that "shall conform to the harmonised standards" when harmonised standards containing indications on symbols or colour coding are available." 

    Mark Swanson's priority list is even mentioned clearly in the following statement in the same exact order (as it is common sense and I've been preaching the same list order for 30+ years since the MDD started) and then talks about doing a risk assessment or gap analysis or similar as others in this thread have already mentioned.  So, it is clear that the MDCG 2021-05 should be a good way to show a Notified Body that if it is drifting that they need to line up with the times.  Some have already changed their policies about standards like NSAI but as Richard and others have mentioned it is still the reviewer you may need to battle with.  It says "in practice...the manufacturer
    may always choose to apply the technical solutions provided by harmonised European standards cited or not cited in the OJEU, or by non-harmonised European standards, or by any other international or national standards, or even to develop its own technical solutions, provided that it is able to demonstrate that these different or alternative non-harmonised means are adequate to comply with the legal requirements applicable to the product. Such a demonstration can be given by the manufacturer through a more in-depth risk assessment, gap analysis, etc., to be reflected in the related technical documents and reports within the prescribed conformity assessment procedures on the product. 


    ------------------------------
    Leonard (Leo) Eisner, P.E.
    The "IEC 60601 Guy"
    Principal Consultant, Eisner Safety Consultants
    Phone: (503) 244-6151
    Mobile: (503) 709-8328
    Email: Leo@EisnerSafety.com
    Website: www.EisnerSafety.com
    ------------------------------



  • 10.  RE: EU MDR and acceptance of ASTM standard

    Posted 04-Aug-2022 14:42
    Check out yesterday's post "...draw up a rationale justifying your customized conformity assessment approach under the corresponding allowance of EU MDR Annex II.4 first paragraph and indent (b), along with corresponding leaning on the MDCG's MDCG 2021-5 acknowledgment of the EU MDR legislative reality that, "...it is not possible to impose the use of a specific standard in the conformity assessment of a product..."

    ------------------------------
    Kevin Randall, ASQ CQA, RAC (Europe, U.S., Canada)
    Principal Consultant
    Ridgway, CO
    United States
    © Copyright 2022 by ComplianceAcuity, Inc. All rights reserved.
    ------------------------------